Know these first
- L1.8.04: An insurer’s balance sheet
- L2.2.06: Insurance risk
Math Atoms
By the end you will be able to
- 1Project mortality improvements and tell period from cohort life expectancy.
- 2Value an annuity as a discounted sum of survival probabilities, and see the geometric series inside it.
- 3Apply the Solvency II longevity stress (−20% on mortality) and explain why longevity is the largest life risk on the book.
- 4Compare longevity swaps, buy-ins and reinsurance, and price the capital relief a swap buys.
Why it matters
RiskAtoms Insurance SE pays 200,000 pensioners €1,696.9m this year, and will keep paying each of them until they die. On its table a 65-year-old lives another 22.9 years. If mortality turns out 20% lighter, that becomes 25.0 years, and the annuities cost €1,887.2m more. That one assumption is the largest risk in the insurer's life business: 9.1 times its mortality risk.
Core explanation
Living longer, priced today
Illustrative dataRiskAtoms Insurance SE's life and health book
The composite European insurer of Modules 1.8 and 2.2, reporting in € millions at 31 December 2025: 200,000 annuitants, 400,000 term assurance policies, three generations of savings contracts with guaranteed rates, and a small income protection book. One unisex Gompertz–Makeham mortality table with 1.5% a year improvement and an illustrative euro curve (not EIOPA's) value them all. Every policy, assumption and figure is made up for teaching and fixed in code; none is any insurer's data. Every lesson in Module 3.8 uses the same book, so the figures agree.
This lesson uses the annuity book: 200,000 annuitants in six age bands from 65 to 90, level pensions of €7,200 to €9,800 a year paid at each year end, and €40 a year of expenses each. The simplifications that matter: one unisex table, a constant 1.5% a year improvement to age 100 (none above), no indexation, and a longevity swap in the book that passes the stress on in full with no counterparty risk.
L3.8.06: Mortality risk built the table. For an annuity the question turns round: not how many die next year, but how long the survivors keep being paid. Longevity risk is the risk that they are paid for longer than assumed.
Improvements: the table moves
Mortality rates at each age have fallen for decades. The book assumes a mortality improvement of 1.5% a year to age 100: the rate for age x in year 2025 + t is qx(1 − 0.015)t, compounding like a negative interest rate (M-A03: Exponents). At 65 it is 1.044% in 2025, 0.897% in 2035 and 0.771% in 2045. At this pace a rate halves in 46 years.
That gives two life expectancies. The period figure uses 2025's rates at every age. The cohort figure follows today's 65-year-olds: at 66 they meet 2026's rate (1.128% rather than 1.145%), at 67 2027's, and so on.
| At 65 | Life expectancy | Reach 90 | Annuity factor a₆₅ |
|---|---|---|---|
| Period (2025 rates throughout) | 20.85 years | 36.2% | 14.895 |
| Cohort (1.5% improvement, the book) | 22.92 years | 45.4% | 15.890 |
| Cohort, mortality −20% (the stress) | 25.04 years | 53.3% | 16.969 |
The curves differ most in the 80s and 90s, which is exactly where an annuity keeps paying. A 20% cut in every rate looks modest in a table, but it adds 2.12 years at 65. The small kink in the cohort curves just after 100 is by design, because the book's improvements stop at age 100.
What an annuity is worth
The annuity factor ax adds up each future year's payment of 1, times the chance of being alive to receive it, times the discount factor. A 65-year-old's €9,800 pension is worth €155,718 on the book basis (a65 = 15.890), and €166,293 after the stress.
| Age | Lives | Pension | a_x | Best estimate | a_x stressed | Stressed | Change |
|---|---|---|---|---|---|---|---|
| 65 | 30,000 | €9,800 | 15.890 | €4,696.6m | 16.969 | €5,015.8m | +€319.3m |
| 70 | 45,000 | €9,300 | 13.526 | €5,691.7m | 14.642 | €6,161.7m | +€470.1m |
| 75 | 50,000 | €8,800 | 11.158 | €4,937.3m | 12.271 | €5,430.5m | +€493.2m |
| 80 | 40,000 | €8,200 | 8.879 | €2,930.0m | 9.947 | €3,282.5m | +€352.5m |
| 85 | 25,000 | €7,700 | 6.783 | €1,314.1m | 7.763 | €1,504.1m | +€189.9m |
| 90 | 10,000 | €7,200 | 4.946 | €358.6m | 5.805 | €420.9m | +€62.3m |
| Book | 200,000 | €19,928.3m | €21,815.5m | +€1,887.2m |
The stress costs €1,887.2m, 9.5% of the best estimate, and the Solvency II longevity charge is that rise. Most of it sits with the 70- and 75-year-olds: young enough to have long to run, and the largest groups.
Why longevity is the largest life risk here
Three things make it large. It is long: an error in the table compounds over 25 or 30 years of payments. It is systematic: every annuitant benefits from the same medical progress, so 200,000 lives diversify the random part (L3.8.06: Mortality risk) but not the trend. And it is one-way for this book: nothing in the annuities gains if people live longer. On the book it is €1,887.2m of the €2,722.8m of life charges before diversification (69%).
The improvement assumption alone moves the best estimate by more than the mortality charge many times over:
| Improvement a year | e₆₅ (cohort) | Annuity best estimate | Against 1.5% |
|---|---|---|---|
| 0.0% | 20.85 years | €18,775.5m | −€1,152.7m |
| 1.0% | 22.20 years | €19,535.6m | −€392.7m |
| 1.5% | 22.92 years | €19,928.3m | book |
| 2.0% | 23.64 years | €20,326.1m | +€397.8m |
| 3.0% | 25.10 years | €21,126.9m | +€1,198.6m |
Sort itDoes the annuity best estimate rise or fall?
Each change is made to the book's assumptions or the world. Sort it.
A new study shows mortality at older ages improving at 2% a year, not 1.5%.
A severe flu season raises deaths among the over-75s for one winter.
Interest rates fall by 50 basis points.
The insurer finds that its annuitants, who are wealthier than average, die 10% less often than the table says.
The insurer writes 10,000 new annuities at a price above their best estimate.
Passing longevity on
Because the risk is systematic and long, insurers and pension schemes pay others to take it. On the book, a longevity swap on 50% of the annuities, at a fee of 2% a year of the hedged payments, halves the longevity charge (to €943.6m) and cuts the SCR by €323.4m, taking the solvency ratio from 186% to 199%. It costs €17.0m a year: 5.2% a year for each euro of capital released.
Four ways to transfer longevity: what goes, what stays?
The formal version
Improvement. The cohort survival from age x uses the rate for age x + s in calendar year 2025 + s:
The period figures set i = 0 inside the projection; the half year allows for deaths during the year. The longevity stress multiplies every q by 0.8, improvement still applied.
The geometric series. If a 65-year-old never aged, surviving each year with p = 1 − q65 = 0.98956, and the rate were a flat 2.5% (v = 0.97561), each term would be the last times r = pv = 0.96543 (M-A07: Geometric series):
The book's a65 is 15.89: real mortality doubles every seven years or so, which cuts the long tail of the series. The closed form is still useful as a check and as the backbone of a pension's duration.
Aggregation. Mortality, longevity and catastrophe enter the life module together, with Article 136's correlations. In full, in € millions:
The three together need less capital than longevity alone (€1,887.2m). The −0.25 between mortality and longevity says that the scenarios which hurt the term book tend to help the annuities.
Try it
The sliders start at the Solvency II stress: mortality 0.8 times the table with the book's 1.5% improvement. Set the multiplier to 1 and change the improvement instead: which assumption matters more? Then move rates to see how far interest rates and longevity compound.
Try itValue the annuities on your assumptions
Model point (age of the annuitants)
The multiplier applies to every future mortality rate; 0.80× with 1.5% improvement is the Solvency II longevity stress. Rates move the illustrative curve in parallel. Pensions are level and paid at each year end, expenses €40 a life a year. Illustrative data.
Worked example
The longevity charge, from one pensioner to the book
All figures from the book; € millions unless stated.
The 65-year-olds, then the annuity book
Step 1 of 6- 1
Rates and improvement
Is the swap worth it?
Regulatory lens
Article 138 of Delegated Regulation (EU) 2015/35 sets the longevity charge as the loss from an instantaneous, permanent 20% fall in mortality rates, applied to the policies where lower mortality increases technical provisions. Because longevity cannot be hedged in markets, it also drives the risk margin, the cost of holding capital for it until the last annuity is paid. The 2025 review cuts the cost-of-capital rate from 6% to 4.75% from 30 January 2027 (Delegated Regulation (EU) 2026/269), with a new factor that shrinks the capital projected for later years. On the book's own cost-of-capital check, the rate change alone takes the risk margin from €1,848m to €1,463m, before the new factor. In the UK, where bulk annuity writers pass annuity books on through funded reinsurance, the PRA's SS5/24 (26 July 2024) expects limits on correlated counterparties and plans for recapturing the assets if a reinsurer fails. The full treatment is in M4.6: Solvency II and insurance regulation.
Spark Atoms
Spark AtomTen years out of date
Spark AtomA £16bn swap
Key takeaways
- Improvements compound: q_x(2025 + t) = q_x(2025)·(1 − i)^t. At 1.5% a year a rate halves in 46 years.
- Period life expectancy uses one year's rates; cohort follows the group. At 65 on the book: 20.85 against 22.92 years, and 25.04 after the −20% stress.
- a_x = Σ ₜpₓ vᵗ, a geometric series when p and v are constant. a₆₅ = 15.89; the annuity best estimate is €19,928.3m.
- The longevity charge is €1,887.2m (9.5% of the best estimate), 69% of the undiversified life charges: long, systematic and one-way.
- A 50% longevity swap cuts the SCR by €323.4m for €17.0m a year, but keeps the assets and adds counterparty risk. Buy-ins move everything.
Reaction
Check what stuck
Question 1 · objective 1
The mortality rate at age 75 is 2.0% today and improves by 1.5% a year. What will the rate at age 75 be in ten years' time, in %, to two decimal places?
Question 2 · objective 2
Suppose an annuitant survived each year with the same probability 0.98 and the rate were a flat 3%. What would 1 a year for life be worth? Use the geometric series, to one decimal place.
Question 3 · objective 1
The book gives a 65-year-old a period life expectancy of 20.85 years and a cohort life expectancy of 22.92. Which should price an annuity sold today?
Question 4 · objective 3
The annuity best estimate is €19,928.3m and the −20% longevity stress raises it by €1,887.2m. By what percentage does the stress raise the best estimate?
Question 5 · objective 4
A 50% longevity swap cuts RiskAtoms Insurance SE's SCR by €323.4m for a fee of €17.0m a year. What does the insurer keep after the swap?
Glossary
- Longevity risk
- Longevity risk: the risk that annuitants and pensioners live longer than assumed, so pensions are paid for more years. It hurts annuities and defined benefit pension schemes.
- Mortality improvement
- Mortality improvement: the yearly fall in the mortality rate at a given age. At 1.5% a year, q at age 65 in ten years' time is 0.985¹⁰ times today's.
- Period life expectancy
- Period life expectancy: computed from one year's mortality rates, as if they never changed. It ignores future improvements.
- Cohort life expectancy
- Cohort life expectancy: follows one group born in the same year through time, using each future year's (projected) rates. Usually higher than period life expectancy.
- Annuity factor
- Annuity factor a_x: the value today of 1 a year paid at each year end for as long as a life aged x survives. A pension's value is the pension times a_x.
- Longevity swap
- Longevity swap: the insurer pays a fixed schedule of expected pensions plus a fee; the counterparty pays the pensions actually due. The insurer keeps its assets and passes on the longevity risk.
- Longevity reinsurance
- Longevity reinsurance: an insurer passes part of its annuitants' longevity risk to a reinsurer, often in the form of a swap.
- Buy-in
- Buy-in: a pension scheme pays an insurer a premium for a bulk annuity policy that pays the scheme its pensions. The scheme keeps the members; the insurer takes the longevity, investment and interest rate risk.
- Buy-out
- Buy-out: as a buy-in, but the members become the insurer's policyholders and the scheme can wind up.
- Basis risk
- Basis risk: the gap between a hedge and what it hedges. An index-based longevity hedge pays on national mortality, not on the insurer's own annuitants.
Deep Dives & Origins
Deep Dives
- Office for National Statistics, “Period and cohort life expectancy explained”, methodology, revised 19 January 2023. Intermediate.
- D. C. M. Dickson, M. R. Hardy and H. R. Waters, Actuarial Mathematics for Life Contingent Risks, 3rd edition, Cambridge University Press, 2020: chapter 5, annuities and their valuation. Advanced.
Origins
- Commission Delegated Regulation (EU) 2015/35, Articles 136 and 138, as adopted, via legislation.gov.uk.
- Commission Delegated Regulation (EU) 2026/269, Article 39 as amended (cost-of-capital rate 4.75%), EUR-Lex.
- Office for National Statistics, “Period and cohort life expectancy explained”, 19 January 2023.
- IPE, “BT Pension Scheme transfers £16bn of longevity risk in mammoth deal”, 2014.
- Reinsurance News, “UK bulk annuity market hits record £47.6bn in 2024: Aon”, 1 April 2025.
- Prudential Regulation Authority, letter “SS5/24 Funded reinsurance: implementation approach”, G. Truran, 26 July 2024.
Watch this lesson
Video version
Prefer to watch? The same lesson as a 12-minute video will sit here, made from this page's script.